The results of a phase 2 randomized clinical trial show the application of the topical antibiotic mupirocin to multiple body sites was safe and efficacious in eradicating Staphylococcus aureus from

Credit: CDC

infants in the neonatal intensive care unit (NICU). The findings were published in Pediatrics.

Read more at CIDRAP

Read more at AAP News and Journals